Amgen reported second-quarter 2026 revenue of $10.1 billion and non-GAAP EPS of $6.29, and raised its full-year revenue and non-GAAP EPS guidance.
Korean translation
Amgen은 2026년 2분기 매출 101억달러와 비GAAP EPS 6.29달러를 보고하고 연간 매출 및 비GAAP EPS 가이던스를 상향함.
Amgen reported second-quarter 2026 revenue of $10.1 billion and non-GAAP EPS of $6.29, and raised its full-year revenue and non-GAAP EPS guidance.
Korean translation
Amgen은 2026년 2분기 매출 101억달러와 비GAAP EPS 6.29달러를 보고하고 연간 매출 및 비GAAP EPS 가이던스를 상향함.